|
SIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72661884789704E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67754699020861E-12 |
| Normal-vs-Stage2 |
5.88030000248096E-08 |
| Normal-vs-Stage3 |
9.10139996701531E-09 |
| Normal-vs-Stage4 |
2.85949042222455E-12 |
| Stage1-vs-Stage2 |
5.082200E-01 |
| Stage1-vs-Stage3 |
7.665800E-01 |
| Stage1-vs-Stage4 |
4.738000E-02 |
| Stage2-vs-Stage3 |
4.665200E-01 |
| Stage2-vs-Stage4 |
4.682800E-01 |
| Stage3-vs-Stage4 |
6.252100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.88054041625219E-13 |
| Normal-vs-AfricanAmerican |
1.5678399999941E-05 |
| Normal-vs-Asian |
2.46969999995184E-06 |
| Caucasian-vs-AfricanAmerican |
9.719600E-01 |
| Caucasian-vs-Asian |
3.149000E-01 |
| AfricanAmerican-vs-Asian |
5.418800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.19424519957101E-13 |
| Normal-vs-Female |
4.42035297254506E-12 |
| Male-vs-Female |
3.378600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.97637478499746E-12 |
| Normal-vs-Age(41-60Yrs) |
3.75049991063747E-11 |
| Normal-vs-Age(61-80Yrs) |
8.63280003038369E-10 |
| Normal-vs-Age(81-100Yrs) |
4.647000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.202600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.063000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.529400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.499200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.104000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.955600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.373200E-01 |
| Classical-VS-Follicular |
2.864900E-03 |
| Classical-VS-Other |
6.339000E-01 |
| Classical-VS-Normal |
7.18469728155924E-12 |
| Tall-VS-Follicular |
4.337700E-02 |
| Tall-VS-Other |
6.609600E-01 |
| Tall-VS-Normal |
3.98589999994758E-06 |
| Follicular-VS-Other |
7.296800E-01 |
| Follicular-VS-Normal |
2.63330468541767E-11 |
| Other-VS-Normal |
2.775200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.86389850407454E-11 |
| Normal-vs-N1 |
2.7005953029402E-11 |
| N0-vs-N1 |
1.390820E-01 |
|
|
